NCT01406782View on ClinicalTrials.gov

DNA Analysis in Influencing Response to Rituximab in Samples From Patients With Follicular Lymphoma Treated on ECOG-E4402

CompletedOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

December 13, 2011

Primary Completion Date

January 13, 2012

Study Completion Date

January 13, 2012

Conditions
Lymphoma
Interventions
BIOLOGICAL

rituximab

GENETIC

DNA analysis

GENETIC

gene expression analysis

GENETIC

polymerase chain reaction

OTHER

laboratory biomarker analysis

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Eastern Cooperative Oncology Group

NETWORK

NCT01406782 - DNA Analysis in Influencing Response to Rituximab in Samples From Patients With Follicular Lymphoma Treated on ECOG-E4402 | Biotech Hunter | Biotech Hunter